Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-week phase 4 study of quetiapine fumarate in drug-naive first-episode psychosis
2005-001069-32Phase 4Active
- Sponsor
- Psychosis Early Detection and Intervention Centre
- Start
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in Schizophrenia Spectrum Disorders (SSD), psychosis, sponsored by Psychosis Early Detection and Intervention Centre. Started May 2005; status: active.
02
Drugs
quetiapine
03
Conditions
Schizophrenia Spectrum Disorders (SSD)psychosis
Beyond the preview
Go deeper on 2005-001069-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001069-32.